BrainQ

BrainQ is a medical technology company that develops AI-powered electromagnetic stimulation therapy for stroke disability recovery. The company investigational therapy uses tailored, low-intensity, low-frequency electromagnetic stimulation to enhance the brain natural recovery process after stroke, designed for safe use in both clinical and home settings. BrainQ AI algorithms analyze patient data to personalize treatment parameters, optimizing the electromagnetic stimulation patterns for each individual recovery trajectory. The technology aims to improve motor function recovery in stroke survivors by modulating neural network activity in affected brain regions, addressing the significant unmet need for effective post-stroke rehabilitation therapies. Founded in 2011 and headquartered in Jerusalem, Israel, BrainQ has raised $48.8 million through Series B funding from investors including Hanaco Ventures, Peregrine Ventures, EIC Fund, Dexcel, and OurCrowd.